Showing 2,371 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Drug interactions & pharmacokinetics

Small Study Finds No Need for Double-Dosing Dolutegravir After Switching From Failing Efavirenz-Based Regimen

Editor's pick
TheBodyPro
17 April 2024
Resistance

Widely used HIV drug in South Africa flagged for reports of resistance – but experts say don’t panic

Editor's pick
Spotlight
16 April 2024
Ethnic & cultural minorities

Health Equity Must Be “The Center of All That We Do” to Reduce Racial/Ethnic Disparities in HIV

Editor's pick
Physician's Weekly
15 April 2024
Adherence

South Africa: I get R7 for every ARV parcel I deliver to patients on my bike

Editor's pick
Bhekisisa
10 April 2024
Bad science & bogus treatments

Posts claim neem leaves heal HIV patients but scientists are yet to find a cure

Editor's pick
AFP Factcheck
5 April 2024
HIV treatment

South Africa: One in four people with HIV not on treatment, according to new estimates

Editor's pick
Spotlight
4 April 2024
HIV treatment

Immunologic Nonresponse in HIV After ART Initiation Tied to Male Sex, Older Age

Editor's pick
Infectious Disease Advisor
2 April 2024
Bad science & bogus treatments

Scientists warn against Facebook posts touting moringa juice HIV 'cure'

Editor's pick
AFP Factcheck
21 March 2024
New & experimental HIV treatments

Drug candidate may 'unmask' latent HIV-infected cells, mark them for destruction

Editor's pick
Medical Xpress
20 March 2024
New & experimental HIV treatments

New Once-Daily HIV Oral Alternative Advances

Editor's pick
Medscape (requires free registration)
9 March 2024
New & experimental HIV treatments

CytoDyn finally clears FDA hold on HIV program after 2 years

Editor's pick
FierceBiotech
8 March 2024
Resistance

New report documents increase in HIV drug resistance to dolutegravir

Editor's pick
World Health Organization
6 March 2024
Injectable & long-acting HIV treatment

Just as CROI Gets Ready to Start, an Important Change to the IAS-USA HIV Treatment Guidelines

Editor's pick
HIV and ID Observations
3 March 2024
Resistance

FDA Expands Indication for Biktarvy to for Resistant HIV

Editor's pick
Infectious Disease Special Edition
1 March 2024
Resistance

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance

Editor's pick
Gilead Sciences press release
27 February 2024
Bad science & bogus treatments

Joe Rogan and Spotify Amplify AIDS Denialism

Editor's pick
POZ
19 February 2024
Adherence

Sufficient PrEP Adherence “May Not Be Attainable” for People Who Inject Drugs

Editor's pick
Physician's Weekly
12 February 2024
Health problems & ageing

Polypharmacy Is Associated With More Falls and Slower Gait Speed in Older People With HIV, Study Reports

Editor's pick
TheBodyPro
12 February 2024
HIV treatment

Doravirine Therapy for HIV Safe, Maintains Long-Term Virologic Suppression

Editor's pick
Infectious Disease Advisor
12 February 2024
Women

Exploring Sex-Specific Features of HIV

Editor's pick
Johns Hopkins Medicine
9 February 2024
HIV treatment

HIV Med Dovato Now Available in Discreet Packaging

Editor's pick
POZ
7 February 2024
New & experimental HIV treatments

CytoDyn announces submission of revised HIV clinical trial protocol to FDA

Editor's pick
CytoDyn press release
6 February 2024
PrEP science

Kidney Function Not Improved in Patients Who Switch to TAF-Based PrEP

Editor's pick
Infectious Disease Advisor
6 February 2024
Starting treatment

Starting HIV Treatment Sooner Leads to Better Immune Recovery

Editor's pick
POZ
1 February 2024